动脉瘤性蛛网膜下腔出血中生物标志物相关研究
Correlation Study of Biomarkers in Aneurysmal Subarachnoid Hemorrhage
DOI: 10.12677/ACM.2023.1392032, PDF,   
作者: 张江成, 刘 波*, 吐尔洪·吐尔逊:新疆医科大学第一附属医院重症医学三科,新疆 乌鲁木齐
关键词: 动脉瘤性蛛网膜下腔出血生物标志物病情评估Aneurysmal Subarachnoid Hemorrhage Biomarker Disease Assessment
摘要: 动脉瘤性蛛网膜下腔出血在全世界范围均有较高的致死率和致残率,作为常见的收治重症监护室的病因,重症监护室的监测仪器能有效帮助医师发现患者病情变化,并及时做出干预措施,但以往的监测手段不能帮助改善患者的最终结局,我们需要发现新的监测手段来帮助临床干预病情改善结局。在这方面,生物标志物的探索是必要的,它有助于了解患者病情变化的生理机制,从而更有效地去改善重症患者结局,减轻家庭及社会的负担。
Abstract: Aneurysmal subarachnoid hemorrhage has a high mortality and disability rate all over the world. As a common cause of admission to intensive care units, monitoring instruments in intensive care units can effectively help doctors find changes in patients’ conditions and make timely interven-tions. However, previous monitoring methods cannot improve the final outcome of patients. We need to find new monitoring methods to help clinical intervention to improve the outcome. In this regard, it is necessary to explore biomarkers, which will help to understand the physiological mechanism of patients’ condition changes, so as to improve the outcome of severe patients more ef-fectively and reduce the burden on families and society.
文章引用:张江成, 刘波, 吐尔洪·吐尔逊. 动脉瘤性蛛网膜下腔出血中生物标志物相关研究[J]. 临床医学进展, 2023, 13(9): 14536-14542. https://doi.org/10.12677/ACM.2023.1392032

参考文献

[1] Rouanet, C. and Silva, G.S. (2019) Aneurysmal Subarachnoid Hemorrhage: Current Concepts and Updates. Arquivos de Neuro-Psiquiatria, 77, 806-814. [Google Scholar] [CrossRef] [PubMed]
[2] Neifert, S.N., Chapman, E.K., Martini, M.L., et al. (2021) Aneurysmal Subarachnoid Hemorrhage: The Last Decade. Translational Stroke Research, 12, 428-446. [Google Scholar] [CrossRef] [PubMed]
[3] English, S.W. (2020) Long-Term Outcome and Eco-nomic Burden of Aneurysmal Subarachnoid Hemorrhage: Are We Only Seeing the Tip of the Iceberg? Neurocritical Care, 33, 37-38. [Google Scholar] [CrossRef] [PubMed]
[4] Ruhatiya, R.S., Adukia, S.A., Manjunath, R.B. and Maheshwarappa, H.M. (2020) Current Status and Recommendations in Multimodal Neuromonitoring. Indian Jour-nal of Critical Care Medicine: Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine, 24, 353-360. [Google Scholar] [CrossRef] [PubMed]
[5] Rivera Lara, L. and Püttgen, H.A. (2018) Multi-modality Monitoring in the Neurocritical Care Unit. Continuum, 24, 1776-1788. [Google Scholar] [CrossRef
[6] Makarenko, S., Griesdale, D.E., Gooderham, P. and Sekhon, M.S. (2016) Multimodal Neuromonitoring for Traumatic Brain Injury: A Shift towards Individualized Therapy. Journal of Clinical Neuroscience, 26, 8-13. [Google Scholar] [CrossRef] [PubMed]
[7] Aronson, J.K. and Ferner, R.E. (2017) Biomarkers—A General Review. Current Protocols in Pharmacology, 76, 9.23.1-9.23.17. [Google Scholar] [CrossRef] [PubMed]
[8] Chauin, A. (2021) The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis. Vascu-lar Health and Risk Management, 17, 601-617. [Google Scholar] [CrossRef
[9] Kaier, T.E., Alaour, B. and Marber, M. (2021) Cardiac Troponin and Defining Myocardial Infarction. Cardiovascular Research, 117, 2203-2215. [Google Scholar] [CrossRef] [PubMed]
[10] Levey, A.S., Coresh, J., Tighiouart, H., Greene, T. and Inker, L.A. (2020) Measured and Estimated Glomerular Filtration Rate: Current Status and Future Directions. Nature Reviews Nephrology, 16, 51-64. [Google Scholar] [CrossRef] [PubMed]
[11] Pinsino, A., Mondellini, G.M., Royzman, E.A., et al. (2020) Cystatin C- versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes among Patients with a Left Ventricular Assist Device. Circulation Heart Failure, 13, e006326. [Google Scholar] [CrossRef
[12] Chou, S.H. and Robertson, C.S. (2014) Moni-toring Biomarkers of Cellular Injury and Death in Acute Brain Injury. Neurocritical Care, 21, 187-214. [Google Scholar] [CrossRef] [PubMed]
[13] Chou, S.H., Macdonald, R.L. and Keller, E. (2019) Biospecimens and Molecular and Cellular Biomarkers in Aneurysmal Subarachnoid Hemorrhage Studies: Common Data Elements and Standard Reporting Recommendations. Neurocritical Care, 30, 46-59. [Google Scholar] [CrossRef] [PubMed]
[14] Lai, P.M. and Du, R. (2016) Association between S100B Levels and Long-Term Outcome after Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Pooled Analysis. PLOS ONE, 11, e0151853. [Google Scholar] [CrossRef] [PubMed]
[15] Wiesmann, M., Missler, U., Hagenström, H. and Gottmann, D. (1997) S-100 Protein Plasma Levels after Aneurysmal Subarachnoid Haemorrhage. Acta Neurochirurgica, 139, 1155-1160. [Google Scholar] [CrossRef
[16] Balança, B., Ritzenthaler, T., Gobert, F., et al. (2020) Sig-nificance and Diagnostic Accuracy of Early S100B Serum Concentration after Aneurysmal Subarachnoid Hemorrhage. Journal of Clinical Medicine, 9, Article 1746. [Google Scholar] [CrossRef] [PubMed]
[17] Kedziora, J., Burzynska, M., Gozdzik, W., et al. (2021) Biomarkers of Neurological Outcome after Aneurysmal Subarachnoid Hemorrhage as Early Predictors at Discharge from an Intensive Care Unit. Neurocritical Care, 34, 856-866. [Google Scholar] [CrossRef] [PubMed]
[18] Amiri, M., Astrand, R. and Romner, B. (2013) Can S100B Pre-dict Cerebral Vasospasms in Patients Suffering from Subarachnoid Hemorrhage? Frontiers in Neurology, 4, Article 65. [Google Scholar] [CrossRef] [PubMed]
[19] Moritz, S., Warnat, J., Bele, S., et al. (2010) The Prognostic Value of NSE and S100B from Serum and Cerebrospinal Fluid in Patients with Spontaneous Subarachnoid Hemorrhage. Journal of Neurosurgical Anesthesiology, 22, 21-31. [Google Scholar] [CrossRef
[20] Tawk, R.G., Grewal, S.S., Heckman, M.G., et al. (2016) The Relationship between Serum Neuron-Specific Enolase Levels and Severity of Bleeding and Functional Outcomes in Patients with Nontraumatic Subarachnoid Hemorrhage. Neurosurgery, 78, 487-491. [Google Scholar] [CrossRef
[21] Sahu, S., Nag, D.S., Swain, A. and Samaddar, D.P. (2017) Biochemical Changes in the Injured Brain. World Journal of Biological Chemistry, 8, 21-31. [Google Scholar] [CrossRef] [PubMed]
[22] Yuan, Y., Chen, J., Zhang, Y., et al. (2022) Exploration of Risk Factors for Poor Prognosis of Non-Traumatic Non-Aneurysmal Subarachnoid Hemorrhage. Biomolecules, 12, 948.
[23] Zhao, H., Shang, F., Qi, M., et al. (2022) Related Factors and a Threshold of the Maximum Neuron-Specific Enolase Value Affecting the Prognosis of Patients with Aneurysmal Subarachnoid Hemorrhage. Applied Bionics and Biomechanics, 2022, Article ID: 7596426. [Google Scholar] [CrossRef] [PubMed]
[24] Kaste, M., Somer, H. and Konttinen, A. (1977) Brain-Type Creatine Kinase Isoenzyme. Occurrence in Serum in Acute Cerebral Disorders. Archives of Neurology, 34, 142-144. [Google Scholar] [CrossRef] [PubMed]
[25] Kettunen, P. (1983) Subarachnoid Haemorrhage and Acute Heart Injury. Clinica Chimica Acta, 134, 123-127. [Google Scholar] [CrossRef] [PubMed]
[26] Kloss, R., Keller, H.E., Stober, T., et al. (1985) [Creatine Ki-nase BB Activity in the Serum of Patients with Cerebrovascular Diseases]. Der Nervenarzt, 56, 417-422.
[27] Coplin, W.M., Longstreth Jr, W.T., Lam, A.M., et al. (1999) Cerebrospinal Fluid Creatine Kinase-BB Isoenzyme Activity and Outcome after Subarachnoid Hemorrhage. Archives of Neurology, 56, 1348-1352. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, Z. and Wang, K.K. (2015) Glial Fibrillary Acidic Protein: From Intermediate Filament Assembly and Gliosis to Neurobiomarker. Trends in Neurosciences, 38, 364-374. [Google Scholar] [CrossRef] [PubMed]
[29] Schiff, L., Hadker, N., Weiser, S. and Rausch, C. (2012) A Litera-ture Review of the Feasibility of Glial Fibrillary Acidic Protein as a Biomarker for Stroke and Traumatic Brain Injury. Molecular Diagnosis & Therapy, 16, 79-92. [Google Scholar] [CrossRef
[30] Katsanos, A.H., Makris, K., Stefani, D., et al. (2017) Plasma Glial Fi-brillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage. Stroke, 48, 2586-2588. [Google Scholar] [CrossRef
[31] Gyldenholm, T., Hvas, C.L., Hvas, A.M. and Hviid, C.V.B. (2022) Serum Glial Fibrillary Acidic Protein (GFAP) Predicts Outcome after Intracerebral and Subarachnoid Hemorrhage. Neurological Sciences, 43, 6011-6019. [Google Scholar] [CrossRef] [PubMed]
[32] Lewis, S.B., Wolper, R.A., Miralia, L., Yang, C. and Shaw, G. (2008) Detection of Phosphorylated NF-H in the Cerebrospinal Fluid and Blood of Aneurysmal Subarachnoid Hemor-rhage Patients. Journal of Cerebral Blood Flow and Metabolism, 28, 1261-1271. [Google Scholar] [CrossRef] [PubMed]
[33] Kövesdi, E., Lückl, J., Bukovics, P., et al. (2010) Update on Protein Biomarkers in Traumatic Brain Injury with Emphasis on Clinical Use in Adults and Pediatrics. Acta Neurochirurgica, 152, 1-17. [Google Scholar] [CrossRef] [PubMed]
[34] Helbok, R., Schiefecker, A., Delazer, M., et al. (2015) Cerebral Tau Is Elevated after Aneurysmal Subarachnoid Haemorrhage and Associated with Brain Metabolic Distress and Poor Functional and Cognitive Long-Term Outcome. Journal of Neurology, Neurosurgery, and Psychiatry, 86, 79-86. [Google Scholar] [CrossRef] [PubMed]
[35] Joswig, H., Korte, W., Früh, S., et al. (2018) Neurodegenerative Cerebrospinal Fluid Biomarkers Tau and Amyloid β Predict Functional, Quality of Life, and Neuropsychological Out-comes after Aneurysmal Subarachnoid Hemorrhage. Neurosurgical Review, 41, 605-614. [Google Scholar] [CrossRef] [PubMed]
[36] Provencio, J.J. (2013) Inflammation in Subarachnoid Hemorrhage and Delayed Deterioration Associated with Vasospasm: A Review. In: Zuccarello, M., Clark, J., Pyne-Geithman, G., Andaluz, N., Hartings, J. and Adeoye, O., Eds., Cerebral Vasospasm: Neurovascular Events after Subarachnoid Hem-orrhage, Springer, Vienna, 233-238. [Google Scholar] [CrossRef] [PubMed]
[37] Al-Mufti, F., Misiolek, K.A., Roh, D., et al. (2019) White Blood Cell Count Improves Prediction of Delayed Cerebral Ischemia following Aneurysmal Subarachnoid Hemorrhage. Neurosurgery, 84, 397-403. [Google Scholar] [CrossRef] [PubMed]
[38] Geraghty, J.R., Lung, T.J., Hirsch, Y., et al. (2021) Systemic Im-mune-Inflammation Index Predicts Delayed Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage. Neuro-surgery, 89, 1071-1079. [Google Scholar] [CrossRef] [PubMed]
[39] Gusdon, A.M., Savarraj, J.P.J., Shihabeddin, E., et al. (2021) Time Course of Peripheral Leukocytosis and Clinical Outcomes after Aneurysmal Subarachnoid Hemorrhage. Frontiers in Neurology, 12, Article 694996. [Google Scholar] [CrossRef] [PubMed]
[40] Ma, X., Lan, F. and Zhang, Y. (2021) Associations between C-Reactive Protein and White Blood Cell Count, Occurrence of Delayed Cerebral Ischemia and Poor Outcome following Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. Acta Neurologica Belgica, 121, 1311-1324. [Google Scholar] [CrossRef] [PubMed]
[41] Lv, S.Y., Wu, Q., Liu, J.P., et al. (2018) Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis. World Neurosurgery, 111, e362-e373. [Google Scholar] [CrossRef] [PubMed]
[42] Zeiler, F.A., Thelin, E.P., Czosnyka, M., et al. (2017) Cerebro-spinal Fluid and Microdialysis Cytokines in Aneurysmal Subarachnoid Hemorrhage: A Scoping Systematic Review. Frontiers in Neurology, 8, Article 379. [Google Scholar] [CrossRef] [PubMed]
[43] Simon, M. and Grote, A. (2021) Interleukin 6 and Aneurysmal Subarachnoid Hemorrhage. A Narrative Review. International Journal of Molecular Sciences, 22, Article 4133. [Google Scholar] [CrossRef] [PubMed]
[44] Chou, S.H., Lo, E.H. and Ning, M. (2014) Plasma-Type Gelsolin in Subarachnoid Hemorrhage: Novel Biomarker Today, Therapeutic Target Tomorrow? Critical Care, 18, Article No. 101. [Google Scholar] [CrossRef] [PubMed]
[45] Kumar, M., Cao, W., Mcdaniel, J.K., et al. (2017) Plasma ADAMTS13 Ac-tivity and von Willebrand Factor Antigen and Activity in Patients with Subarachnoid Haemorrhage. Thrombosis and Haemostasis, 117, 691-699. [Google Scholar] [CrossRef
[46] Boluijt, J., Meijers, J.C.M., Rinkel, G.J.E. and Di Vergouwen, M. (2015) Hemostasis and Fibrinolysis in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Sys-tematic Review. Journal of Cerebral Blood Flow and Metabolism, 35, 724-733. [Google Scholar] [CrossRef] [PubMed]
[47] Wan, H., Wang, Y., Ai, J., et al. (2018) Role of von Willebrand Factor and ADAMTS-13 in Early Brain Injury after Experimental Subarachnoid Hemorrhage. Journal of Thrombosis and Haemostasis, 16, 1413-1422. [Google Scholar] [CrossRef] [PubMed]
[48] Bergström, A., Staalsø, J.M., Romner, B. and Olsen, N.V. (2014) Impaired Endothelial Function after Aneurysmal Subarachnoid Haemorrhage Correlates with Arginine: Asymmetric Dimethylarg-inine Ratio. British Journal of Anaesthesia, 112, 311-318. [Google Scholar] [CrossRef] [PubMed]
[49] Appel, D., Seeberger, M., Schwedhelm, E., et al. (2018) Asymmetric and Symmetric Dimethylarginines Are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage. Neurocritical Care, 29, 84-93. [Google Scholar] [CrossRef] [PubMed]
[50] Koch, M., Acharjee, A., Ament, Z., et al. (2021) Machine Learn-ing-Driven Metabolomic Evaluation of Cerebrospinal Fluid: Insights into Poor Outcomes after Aneurysmal Subarachnoid Hemorrhage. Neurosurgery, 88, 1003-1011. [Google Scholar] [CrossRef] [PubMed]